Mergers & Acquisitions
The pharmaceutical company's share price is up 9 percent after the report to TASE
Hi, what are you looking for?
The pharmaceutical company's share price is up 9 percent after the report to TASE
Perrigo Company Plc, the Irish-based generic drugmaker trying to fend off a hostile bid by Mylan NV, held unsuccessful talks to acquire Endo International...
Court rules that Mylan provided adequate public disclosures.
Mylan could settle for buying control of Perrigo, rather than full ownership, keeping Perrigo listed on the TASE.
Teva will pay over $45 billion for the botox maker unit, report the "Wall Street Journal."
Dutch Stichting Foundation notified Mylan that it has exercised its call option to acquire 488, 388, 431 Mylan preferred shares pursuant to the...
Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) has completed first step to buy its rival Mylan N.V. (Nasdaq: MYL). The Israeli giant announced...
Teva is now close to the 4.6% stake in Mylan that will give it standing in the Netherlands courts.
Mylan has confirmed it will dual list on the TASE and Nasdaq if it acquires Perrigo
A Credit Suisse study finds that most hostile bids fail, especially if antitrust concerns are involved.